chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash, Scratch, Urticaria
Clinical narrative: Shortly after injection started itching. Then when  she got home she started a rash on face, chest.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itching and rash/ hives.  Itching started approximately 5 minutes after injection, slight at first then itching increased throughout body. Rash hoed later. Mostly only on areas scratched (face, chest and neck). Rash and itching present for 5 days including day injection given.  Used over the counter antihistamines round the clock. Used inhaler once evening of injection day and once 3 days later. (Albuterol)
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Rash, Scratch, Urticaria
Clinical narrative: Itching and rash/ hives.  Itching started approximately 5 minutes after injection, slight at first then itching increased throughout body. Rash hoed later. Mostly only on areas scratched (face, chest and neck). Rash and itching present for 5 days including day injection given.  Used over the counter antihistamines round the clock. Used inhaler once evening of injection day and once 3 days later. (Albuterol)
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Diarrhoea
Clinical narrative: Non productive cough; diarrhea; This is a spontaneous report from a contactable other healthcare professional (HCP). A 36-year-old male patient received 1 dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EJ1685) intramuscular on right arm on 23Dec2020 03:15PM, single dose for COVID-19 immunization at 36-year-old. Medical history included: allergies: promethazine hydrochloride (PHENERGAN). Prior to vaccination, the patient did not diagnose with COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24Dec2020, 05:00AM, the patient experienced non-productive cough, diarrhea. No treatment received. Since the vaccination, the patient had not been tested for COVID-19. Action taken for BNT162B2 was not applicable. Outcome of the events was not resolved. It was reported as non-serious.  No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Fever, 100.4, sore arm
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site pain, Myalgia
Clinical narrative: Injection site soreness 10 hours post administration; Still sore injection site this morning; Mild headache, muscle achiness and chills also 10 hours post administration of vaccine; Mild headache, muscle achiness and chills also 10 hours post administration of vaccine; Mild headache, muscle achiness and chills also 10 hours post administration of vaccine; This is a spontaneous report from a contactable other HCP. This 47-year-old female other HCP (patient) reported for self that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EK9231) intramuscularly at the right arm at single dose for COVID-19 immunization on 23Dec2020; 09:45 AM. Relevant medical history included Asthma, Ulcerative Colitis and allergies to Penicillin, Fiorinal with Codeine. The patient received Ibuprofen, Mesalamine, Pantoprazole within 2 weeks of vaccination. The patient experienced injection site soreness 10 hours post administration on 23Dec020, mild headache, muscle achiness and chills also 10 hours post administration of vaccine. The patient felt better in the next morning on 24Dec2020, while she still had sore injection site this morning. No treatment was received. The final outcome of events was resolved. All events were considered as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Flushing, Oropharyngeal pain
Clinical narrative: About 5 min after receiving IM Pfizer COVID injection, patient developed flush feeling, dizziness, and sore throat. Taken to ED for evaluation. Monitored for approximately 1 hour with resolution of symptoms.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count, Hypoaesthesia, Hypoaesthesia oral, Lip swelling, Metabolic function test
Clinical narrative: Received vaccine at 1:30 pm yesterday, noted onset of symptoms at 8:45 pm.  Numbness and tingling to mouth and bilateral upper and lower extremities, mild vision change, feeling of some swelling to bilateral eyelids.  Also swelling to lips.  She also did take zinc gluconate 50 mg last night and this morning.  Has never taken zinc 50 mg, but has taken zinc as component of multivitamin/pre-natal vitamins.   Patient was prescribed Pepcid 20 mg BID, Medrol 4 mg dose pack 21 pill taper until complete.  Also given Benadryl 25 mg - 50 mg every 4 - 6 hours for allergy symptoms.  And provided with an Epi-Pen for home.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Paraesthesia oral, Swelling of eyelid, Visual impairment
Clinical narrative: Received vaccine at 1:30 pm yesterday, noted onset of symptoms at 8:45 pm.  Numbness and tingling to mouth and bilateral upper and lower extremities, mild vision change, feeling of some swelling to bilateral eyelids.  Also swelling to lips.  She also did take zinc gluconate 50 mg last night and this morning.  Has never taken zinc 50 mg, but has taken zinc as component of multivitamin/pre-natal vitamins.   Patient was prescribed Pepcid 20 mg BID, Medrol 4 mg dose pack 21 pill taper until complete.  Also given Benadryl 25 mg - 50 mg every 4 - 6 hours for allergy symptoms.  And provided with an Epi-Pen for home.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Paraesthesia
Clinical narrative: Tingling in upper body, heat, warm
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site mass, Injection site pain, Injection site pruritus
Clinical narrative: Medium area of redness, lump, itchy and sore around area of injection.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain, Pain
Clinical narrative: Headache, body aches, fatigue, injection site pain; Headache, body aches, fatigue, injection site pain; Headache, body aches, fatigue, injection site pain; Headache, body aches, fatigue, injection site pain; This is a spontaneous report from a contactable Nurse (patient). A 55-year-old female patient (No pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Intramuscular on 22Dec2020 10:30 AM on Right arm for COVID-19 immunization. Medical history was diagnosed with COVID-19 prior to vaccination. Concomitant drug was not reported. No other vaccine in four weeks. Adverse event reported as Headache, body aches, fatigue, injection site pain (all was non-serious) on 23Dec2020 12:00 AM with outcome was Recovering. No treatment. No COVID prior vaccination. No COVID tested post vaccination. Since the vaccination, the patient was not been tested for COVID-19. Information about lot/batch number are requested.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Ear discomfort, Ear pruritus, Hyperhidrosis, Paraesthesia ear
Clinical narrative: went to observation area at 1045.  called to observation area 1100.  states sx started at 1055:  inside ears tingling, itching and warm.  sweaty armpits.  states has eaten peanutbutter, snacks and coffee for intake today.  not lightheaded, dizzy, states no other sx.  1102 seen by, RN from rapid response.  decided to wait 10 minutes to see if sx resolve.  1115 still no change in sx,  ed called and transported to ED at 1125.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain, Myalgia, Nausea
Clinical narrative: Headache; fatigue; nausea; muscle soreness; injection site pain; This is a spontaneous report from a contactable healthcare professional, the patient. A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EH9899) solution for injection in the left arm on 23Dec2020 at 13:30 (at the age of 32-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. There was no medical history. Concomitant medications included amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL) and sertraline. The patient had no known allergies. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 23Dec2020 at 18:00, the patient experienced headache, fatigue, nausea, muscle soreness, and injection site pain. No treatment was provided for the events headache, fatigue, nausea, muscle soreness, and injection site pain. The outcome of the events headache, fatigue, nausea, muscle soreness, and injection site pain was recovering. Since the vaccination, the patient has not been tested for COVID-19.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Pain, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: 12/23 @ 2000: severe chills 12/24 @ 0100: severe chills, nausea, vomiting, body aches, fever of 102.4 12/24 @ 0900: body aches, fever of 101.5 12/25 @ 0800: body aches, fever of 100.8
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: 12/23 @ 2000: severe chills 12/24 @ 0100: severe chills, nausea, vomiting, body aches, fever of 102.4 12/24 @ 0900: body aches, fever of 101.5 12/25 @ 0800: body aches, fever of 100.8
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Diarrhoea, Headache, Nausea, Vomiting
Clinical narrative: headaches; dehydration; nausea; vomiting; diarrhea; This is a spontaneous report from a contactable healthcare professional, the patient. A 33-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EJ1685) solution for injection in the right arm on 22Dec2020 at 15:45 (at the age of 33-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history was unknown. Concomitant medications included amoxicillin, diphenhydramine hydrochloride (BENADRYL) and birth control. Past drug history included known allergies: cyclobenzaprine. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 23Dec2020 at 08:15, the patient experienced headaches, dehydration, nausea, vomiting and diarrhea. No treatment was provided for the events headaches, dehydration, nausea, vomiting and diarrhea. The outcome of the events headaches, dehydration, nausea, vomiting and diarrhea was unknown. Since the vaccination, the patient has not been tested for COVID-19.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Malaise, Nausea
Clinical narrative: Diarrhea , nausea, 'feeling unwell', fatigued began at 9am the next day - it is currently 3pm - continuing to feel symptoms
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Dizziness
Clinical narrative: lightheadedness; confusion; This is a spontaneous report from a non-contactable healthcare professional. A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EH9899) solution for injection intramuscular in the left arm on 22Dec2020 at 15:45 (at the age of 34-years-old) as a single dose for COVID-19 vaccination. Pregnancy status was not provided at the time of vaccination. Medical history and concomitant medications were unknown. Past drug history was unknown. On 22Dec2020 during her 15 minutes waiting period after the injection, the patient began to experience lightheadedness and confusion. The patient denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling. The patient was discharged stable to go home and follow up with PCP (primary care physician). The patient was released at 16:39 with no symptoms at that time. No treatment was provided for the events lightheadedness and confusion. The outcome of the events lightheadedness and confusion was recovered on 22Dec2020.  No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Employee developed a severe headache approximately 10 minutes after vaccine administration.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Vomiting
Clinical narrative: Extreme fatigue and nausea and vomiting; Extreme fatigue and nausea and vomiting; Extreme fatigue and nausea and vomiting; This is a spontaneous report from a contactable nurse. A 40-years-old female patient started to the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Batch/lot number: Unknown, intramuscularly on 23Dec2020 11:30 (at the age of 40-years-old) as a single dose in the right arm  for COVID-19 immunization.  The patient did not have allergies to medications, food, or other products. Concomitant medication included metformin, zolpidem tartrate (AMBIEN), venlafaxine hydrochloride (EFFEXOR XR). The most recent COVID-19 vaccine was administered in the hospital. The patient was not pregnant at the time of vaccination.  Prior to vaccination, the patient was not diagnosed with COVID-19. On 23Dec2020 14:30, the patient experienced extreme fatigue and nausea and vomiting.  The extreme fatigue and nausea and vomiting did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. No treatment was received for the event. Outcome of the event extreme fatigue and nausea and vomiting was recovering. Since the vaccination, the patient has not been tested for COVID-19. Information on lot/batch number has been requested.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysphonia, Fatigue, Flushing, Myalgia
Clinical narrative: muscle ache, fatigue, hoarse throat, flushed skin, chills
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity
Clinical narrative: Sore arm; nausea; This is a spontaneous report from a contactable nurse reporting for self.  A 43-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Lot# EH9899, via an unspecified route of administration in the right arm on 19Dec2020 at 15:30 (at the age of 43-years-old), as a single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The vaccine was administered in a hospital facility. There was no prior COVID-19 vaccination. The patient was not diagnosed with COVID-19 prior to vaccination & not COVID tested post vaccination. Medical history was none.  Concomitant medications were not reported; however, there were no other medications the patient received within 2 weeks of the vaccination. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. There were no known allergies to medication, food, or other products. The patient experienced sore arm for 24 hours, then from about 34-72 hours had nausea. The onset date and time for the events was reported as 19Dec2020 at 15:30. The events were reported as non-serious. There was no treatment for the events. The patient recovered from the sore arm  and nausea on an unspecified date.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Hypoacusis, Hypoaesthesia, Hypoaesthesia oral, Immediate post-injection reaction
Clinical narrative: hearing in his left ear started sounding muffled; I was given the shot and instantly, within 30 seconds felt a slight numbing feeling radiating up my arm, then to my neck and up the left side of my face.My tongue felt a little numb but not swollen; had that "metal" taste in my mouth, but that did not return; This is a spontaneous report from a contactable other HCP. A 58-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (lot number EL1284), intramuscularly in the left arm on 23Dec2020 at 07:00 (at the age of 58-years-old) as a single dose for COVID-19 immunization. Medical history included high blood pressure from an unknown date and unknown if ongoing and latex allergy from an unknown date and unknown if ongoing. There were no other vaccines received within 4 weeks of the BNT162B2 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included nebivolol hydrochloride (BYSTOLIC), fish oil (FISH OIL), naproxen sodium (ALEVE) and bifidobacterium lactis (PROBIOTIC [BIFIDOBACTERIUM LACTIS]). On 23Dec2020 at 07:00 (within 30 seconds of the vaccination as reported), the patient felt a slight numbing feeling radiating up his arm, then to his neck and up the left side of his face. Then, within 15 minutes, his hearing in his left ear started sounding muffled. His tongue felt a little numb but not swollen. It was reported when he first started feeling the numbing feeling, for about a split second, he had a metal taste in his mouth, but that did not return. It took about 1.5 hours for the numbness to go away. No therapeutic measures were taken as a result of the events. Clinical outcome of the numbness was resolved on 23Dec2020 at 08:30. Clinical outcome of the metal taste in his mouth and hearing in his left ear sounded muffled was unknown. It was also reported that since the vaccination, the patient tested negative for COVID-19 on 23Dec2020.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative
Clinical narrative: hearing in his left ear started sounding muffled; I was given the shot and instantly, within 30 seconds felt a slight numbing feeling radiating up my arm, then to my neck and up the left side of my face.My tongue felt a little numb but not swollen; had that "metal" taste in my mouth, but that did not return; This is a spontaneous report from a contactable other HCP. A 58-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (lot number EL1284), intramuscularly in the left arm on 23Dec2020 at 07:00 (at the age of 58-years-old) as a single dose for COVID-19 immunization. Medical history included high blood pressure from an unknown date and unknown if ongoing and latex allergy from an unknown date and unknown if ongoing. There were no other vaccines received within 4 weeks of the BNT162B2 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included nebivolol hydrochloride (BYSTOLIC), fish oil (FISH OIL), naproxen sodium (ALEVE) and bifidobacterium lactis (PROBIOTIC [BIFIDOBACTERIUM LACTIS]). On 23Dec2020 at 07:00 (within 30 seconds of the vaccination as reported), the patient felt a slight numbing feeling radiating up his arm, then to his neck and up the left side of his face. Then, within 15 minutes, his hearing in his left ear started sounding muffled. His tongue felt a little numb but not swollen. It was reported when he first started feeling the numbing feeling, for about a split second, he had a metal taste in his mouth, but that did not return. It took about 1.5 hours for the numbness to go away. No therapeutic measures were taken as a result of the events. Clinical outcome of the numbness was resolved on 23Dec2020 at 08:30. Clinical outcome of the metal taste in his mouth and hearing in his left ear sounded muffled was unknown. It was also reported that since the vaccination, the patient tested negative for COVID-19 on 23Dec2020.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Headache, Hypertension, Injection site pain, Pain
Clinical narrative: Headache, body aches and pain, lower back pain, high blood pressure, injection site soreness
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: severe shoulder pain/injection in left shoulder once, close to shoulder higher up; states it was not on the deltoid, it was given higher than normal; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number EJ1685, on 23Dec2020 13:30 at single dose by injection in left shoulder once, close to shoulder higher up for COVID-19 immunization. Medical history and concomitant medication were none. The patient received the shot yesterday, and her only experience she was having was severe shoulder pain, and she was wondering if it was possible to just take Aleve, they mentioned taking Tylenol, but she was wondering if Naprosyn was ok to take. Towards yesterday evening, she noticed the severe shoulder pain, she received it at 1:30 in the afternoon, and noticed probably around 9PM, all night was just pain like as if someone or else you overexert with exercise, that kind of pain. She hadn't taken anything, she wondered if it was ok to take Aleve, no one seemed to know. She stated the dose was not given on the deltoid, it was given higher than normal. The outcome of severe shoulder pain was not resolved.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Facial paralysis, Facial paresis, Fatigue
Clinical narrative: Weakness in the left side of face; and fatigue. 1112 am went to observe patient in her room. Laying in the bed with left side droopiness to face. Weakness on left side only, nurse taking care of her stated just happened. On observation it appears to be Bells Palsy reaction. No treatment at the time, Hospice nurse is to visit her today and check on her. Staff will check on her every 30 min for the next few hours and do a pulse oximeter check every hour for next few hours. 1205 second check on patient in room prior to staff leaving. Patient squeezed my hand and opened her eyes on command. Pulse saturation was 95 per staff. Patient resting comfortable with no signs of trouble breathing.
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: I don't feel so good; This is a spontaneous report from a non-contactable consumer, the patient. A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unknown date as a single dose for COVID-19 vaccination. Medical history was unknown. The patient's concomitant medications were not reported. On an unknown date, the patient reported "I don't feel so good and I don't want to go to the hospital." The clinical outcome of " don't feel so good" was unknown.    No follow-up attempts are possible. Information on the lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: pruritic rash in pubic area moving up; This is a spontaneous report from a contactable nurse (patient). A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number:EH9899), via an unspecified route of administration in the left arm on 21Dec2020 at 11:00 AM as a single dose for COVID-19 vaccination. Medical history included cardiomyopathy and hypothryroid. The patient did not have any allergies to medications, food, or other products. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported; however, there were other medications the patient received within 2 weeks of the vaccination. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 22Dec2020 at 08:00 AM, the patient experienced pruritic rash in pubic area moving up. The report was reported as non-serious. The patient was not treated for pruritic rash in pubic area moving up. The clinical outcome of pruritic rash in pubic area moving up was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain
Clinical narrative: chills; body aches; fatigue; This is a spontaneous report from a contactable consumer. This consumer reported that a 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the right arm on 23Dec2020 at 03:00 PM ((at the age of 54 years-old) as a single dose for COVID-19 vaccination. Medical history was unknown. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 23Dec2020 at 10:00PM, the patient experienced chills, body aches, fatigue. The report was reported as non-serious. The patient was not treated for chills, body aches, fatigue. The clinical outcome chills, body aches, fatigue was recovered on an unknown date in Dec2020. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 73.0
Sex: M
Vaccine: FLU4
Symptoms: Wrong product administered
Clinical narrative: Fluzone was administered instead of Flublock
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Fever; Headaches; Chills; Aches and pains; This is a spontaneous report from a contactable consumer (patient herself).   This 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on 23Dec2020 at 08:30 AM at single dose for COVID-19 immunisation. Vaccine location was left arm.  The patient was vaccinated at hospital, age at vaccination was 60-year-old. She was not pregnant. No other vaccine was received in four weeks.  Relevant medical history included diabetic, allergies to eggs, chicken and latex. It was reported that prior to vaccination, she was diagnosed with COVID-19. Relevant concomitant medications included insulin aspart (NOVOLOG) for diabetes. On 24Dec2020, at 02:30 AM, the patient developed fever, headaches, chills, aches and pains. The patient was treated for the events. Nasal swab, COVID test (rapid) was performed on 24Dec2020 and was negative. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Skin warm
Clinical narrative: I noticed onset of a mild rash down my bilateral arms and along my hips, back and legs. This rash worsened upon inspection on 24Dec2020 with associated itching and warmth along the rash site; warmth along the rash site; I noticed onset of a mild rash down my bilateral arms and along my hips, back and legs. This rash worsened upon inspection on 24Dec2020 with associated itching and warmth along the rash site; This is a spontaneous report from a contactable Other HCP.  A 25-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Batch/lot number: EK5730) via an unspecified route of administration on 22Dec2020 at 18:15 (at the age of 25-years-old) at an unspecified dose in the right arm for COVID-19 vaccination. Medical history was not provided. The patient had no allergies to food or medications but reported having seasonal allergies and it was reported that prior to vaccination the patient was diagnosed with COVID-19 on an unspecified date. The patient was administered the vaccine in the hospital. Concomitant medication included an unspecified oral contraceptive. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Dec2020 14:00, the patient noticed the onset of a mild rash down her bilateral arms and along her hips, back and legs. This rash worsened upon inspection on 24Dec2020 with associated itching and warmth along the rash site. The patient did not receive any treatment for the events. The clinical outcomes of the events were reported as not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia
Clinical narrative: Aches; Headache; Fever 102 degrees; This is a spontaneous report from a contactable physician, the patient.  A 59-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EJ1685), via an unspecified route of administration in the left arm on 23Dec2020 at 08:00 (at the age of 59-years-old) as a single dose for COVID-19 immunization.  Medical history included asthma and penicillin allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included naproxen sodium (ALEVE) and unspecified multivitamins (MANUFACTURER UNKNOWN).  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Dec2020 at 07:00, the patient aches, headache, and fever of 102 degrees Fahrenheit, reported as non-serious.  The patient was not treated for the events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcomes of aches, headache, and fever of 102 degrees Fahrenheit were not recovered.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Dyspnoea, Feeling abnormal, Palpitations
Clinical narrative: Lightheadedness an dyspnea after receiving COVID 19 vaccine. Patient states that 5 minutes after receiving the vaccine, he felt "out of it." He felt like he was "in a dream." He reported feeling palpitations, shortness of breath, and chest pain. He denies feeling overly anxious. He states that the chest pain is substernal with no radiation. He reports it is pleuritic in nature. He states it is currently a 4/10, feels like a pressure on this chest; He received 50mg Benadryl and 0.3mg epi x2 by EMS and was brought to the ED for further evaluation.  Admitted from ED for observation on 12/18/2020 and discharged on 12/20/2020.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymphadenopathy: 0.5 cm left arm tender lymph node and 2 cm left infraclavicular tender lymph node; Lymphadenopathy: 0.5 cm left arm tender lymph node and 2 cm left infraclavicular tender lymph node; This is a spontaneous report from a contactable physician reporting for herself. A 49-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot #: EH9899), via an unspecified route of administration on 16Dec2020 at 09:00 (at the age of 49-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history and concurrent conditions were reported as "none". The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications ("other medications in two weeks") included valaciclovir hydrochloride (VALTREX) taken for an unspecified indication from an unspecified date and unspecified if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received sulfa (sulfonamide) on an unspecified date for an unspecified indication and experienced allergy. On 22Dec2020, the patient experienced lymphadenopathy: 0.5 cm left arm tender lymph node and 2 cm left infraclavicular tender lymph node. It was reported that the event was non-serious and did not require hospitalization. The patient did not receive any treatment for the event. The clinical outcome of the event lymphadenopathy: 0.5 cm left arm tender lymph node and 2 cm left infraclavicular tender lymph node was not recovered/not resolved. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Hypertension, Paraesthesia oral, Urticaria
Clinical narrative: "  Code called for a 36 YOF complaining of anaphylactic reaction after receiving COVID vaccine. Per staff, patient began to have hives around mouth and a tingling in mouth. RN on scene administered epi pen at 1310. Patient found awake and alert, in no distress. Team took over care of patient to bring down to ER. Pt VS WNL: BP 158/80, HR 122, RR 18 (post epi pen). Skin parameters WNL with vanishing hives. Patient brought to ED 09 for evaluation. "
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza, Myalgia, Vomiting
Clinical narrative: vomited; muscle pain.; severe flu symptoms for about 4 hours; This is a spontaneous report from a contactable healthcare professional, the patient. A 58-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot# EL1284), via an unspecified route of administration in the right arm on 23Dec2020 at 10:45 (at the age of 58-years-old) as a single dose for Covid-19 vaccination. Medical history was not reported. The patient did not have any allergies to medications, food or other products. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not tested for COVID-19 post vaccination. The patient's concomitant medications were unspecified (had received other medications in two weeks). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Dec2020 at 00:00, the patient experienced severe flu symptoms for about 4 hours, vomited and had muscle pain. Therapeutic measures were not taken for the severe flu symptoms for about 4 hours, vomited and had muscle pain. The clinical outcome of the events severe flu symptoms for about 4 hours, vomited and had muscle pain was recovered.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Influenza like illness, Nausea
Clinical narrative: About 12 hours following the vaccine, I suddenly felt like I had the flu - shivers, shakes, nausea, headache, fatigue but no fever. I went to bed and woke up the next morning and felt back to normal. I was fatigued the second day and had a very sore arm.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Tremor
Clinical narrative: About 12 hours following the vaccine, I suddenly felt like I had the flu - shivers, shakes, nausea, headache, fatigue but no fever. I went to bed and woke up the next morning and felt back to normal. I was fatigued the second day and had a very sore arm.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Severe headache; fever; chills; fatigue; This is a spontaneous report from a contactable nurse, the patient. A 40-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscularly on 23Dec2020 at 18:15 (at the age of 40-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included multiple sclerosis and hypothyroidism. The patient had no known allergies. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included duloxetine hydrochloride (CYMBALTA), gabapentin, cefixime (FLEXERIL), tolterodine, levothyroxine, liothyronine; all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. The patient experienced severe headache, fever, chills, and fatigue on 23Dec2020 at 18:30. No treatment was received for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the severe headache, fever, chills, and fatigue were recovering.   Information on the lot/batch number has been requested.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Oedema peripheral
Clinical narrative: Armpit of injected arm swollen and sore; Armpit of injected arm swollen and sore; This is a spontaneous report from a contactable healthcare professional, the patient. A 29-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot ek5730) solution for injection in the left arm on 19Dec2020 at 14:00 (at the age of 29-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included fibromyalgia, depression, anxiety and ADHD (attention deficit hyperactivity disorder). Concomitant medications were unknown. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 20Dec2020, the patient experienced armpit of injected arm swollen and sore. No treatment was provided for the event armpit of injected arm swollen and sore. The outcome of the event armpit of injected arm swollen and sore was recovering. Since the vaccination, the patient has not been tested for COVID-19.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Mouth swelling, Paraesthesia
Clinical narrative: Reported paresthesia on the left side of her face and swelling of the lower part of her mouth an hour after administration of the Moderna COVID-19 vaccine.  These symptoms resolved by this morning.  She was observed for 15 minutes (as directed) following the vaccine and symptoms were not observed by clinic staff.  She was advised to contact her personal physician for recommendations.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea, Hyperhidrosis
Clinical narrative: Unsure if side effect of vaccine but experiencing sweating, abdominal cramps and diarrhea.; Unsure if side effect of vaccine but experiencing sweating, abdominal cramps and diarrhea.; Unsure if side effect of vaccine but experiencing sweating, abdominal cramps and diarrhea.; This is a spontaneous report from a contactable Nurse.  A 41-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot and batch number unknown) via an unspecified route of administration at an unknown dose in the right arm on 23Dec2020 at 12:45 (at the age of 41-years-old) for COVID-19 immunization. Medical history included asthma, anxiety, arthritis, fibromyalgia and surgical menopause all from unknown dates and unknown if ongoing. The patient did not have any allergies to medications, food or other products. Prior to the vaccination the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. The patient was administered the vaccination in the hospital. Concomitant medication included meloxicam (MELOXICAM), estradiol (ESTRADIOL), gabapentin (GABAPENTIN), phentermine (PHENTERMINE), melatonin (MELATONIN), aminobenzoic acid, biotin, calcium pantothenate, choline bitartrate, cyanocobalamin, folic acid, inositol, nicotinamide, pyridoxine hydrochloride, riboflavin, thiamine mononitrate (B COMPLEX), collagen (COLLAGEN). The patient did not receive any other vaccines within four weeks prior to the vaccination.  The patient stated that she was unsure if these were side effect of vaccine but on 25Dec2020 at 10:00 she was experiencing sweating, abdominal cramps and diarrhea. The clinical outcomes of sweating, abdominal cramps and diarrhea were reported as recovering. It was also reported that since the vaccination the patient had not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose normal, Dysphagia, Hypoaesthesia, Neurological examination normal, Paraesthesia
Clinical narrative: Describes left face, arm, leg felt numbness/tingling Had first COVID shot on 12/20/2020 19:36 then while driving home felt L face numbness at 20:37 Went to ED, BP 167/107 "...driving home she states that she developed a strange, difficult to describe sensation when she was swallowing in her car, this started around 8:37 p.m.. She states that her numbness generalized to involve the entire left side of her face on the left side of her body including her left upper and left lower extremity. She denies any weakness. She denies any dysarthria or noticeable facial droop, she does not feel like she is walking differently. She denies any headaches or visual changes, denies any dizziness, chest pain, shortness of breath, palpitations. She states she has never had anything like this before." ED notes had a normal neuro exam POCT glucose was normal at 83 resolved after minutes to hours in ED
Age: 1.83
Sex: F
Vaccine: COVID19
Symptoms: Vaginal infection
Clinical narrative: Vaginitis; This is a spontaneous report from a contactable healthcare professional.  A 22-month-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at the left arm from 23Dec2020 13:00 at a single dose for COVID-19 immunization at a hospital.  The patient medical history was not reported.  The patient's concomitant medications were not reported.  The patient experienced vaginitis on 24Dec2020 13:00 which was reported to be treated with an unspecified OTC. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for it since the vaccination. The patient was recovering from the event.   Information on the batch number has been requested.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received the first dose on BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on 18Dec2020 at single dose for COVID-19 immunization. Medical history was reported as none. Concomitant medications were not provided. Patient stated that she had her COVID shot on 18Dec2020 (reported as last Friday) and she had a headache ever since. Patient was just taking Ibuprofen trying to get rid of the headache. Outcome of the event was unknown. Information on lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: developed some tingling, kind of a shock that comes and goes in her arms and in her back; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899) via an unspecified route of administration on 23Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient took the vaccine yesterday on 23Dec2020 and she developed some tingling, kind of a shock that comes and goes in her arms and in her back. She watched it for a long time, as nurses like to watch, and she finally feel asleep, so she wanted to tell this, she didn't know if this is any danger to her, she didn't think so, she was breathing well and can talk, but she was concerned because the tingling was almost like a little shock that comes and goes, not permanent. The reporter wanted to know if anyone has reported this. She was about to go out, but decided to call, agent can't say if this is something reported and she need to go to the local hospital. The outcome of the event was unknown.  Information on the Lot/batch number has been requested.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Urinary tract infection
Clinical narrative: UTI; This is a spontaneous report from a contactable consumer.  A 65-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration, left upper arm on 22Dec2020 12:30 at a single dose for COVID-19 immunization at a hospital. Medical history included urinary tract infection (UTI) in 2018 (2 years ago). There were no concomitant medications as the patient does not take any prescription drugs. Patient thinks her urinary tract infection (UTI) started to develop, 28-29 hours after receiving the vaccine so the onset was 23Dec2020. Patient stated the UTI came on fast and she has an appointment with an urgent care and may need antibiotics to treat the UTI. Patient was drinking a lot of fluids to try to flush the UTI out of her system. She said she doesn't feel as bad and felt like the UTI was getting better, and just woke up a short time ago. Patient also stated that she is concerned the antibiotic will mess up the vaccine, and wanted to know if she can take an antibiotic so soon after receiving the vaccine. The patient was recovering from the event.   . .
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: Rash all over body, very itchy; Rash all over body, very itchy; This is a spontaneous report from a contactable nurse reporting for herself.  A 62-year-old female patient received bnt162b2 (BNT162B2, Batch/lot # EJ1685) at single dose at left deltoid on 20Dec2020 in the afternoon around 13:30-13:45 for covid-19 immunisation, administered by a nurse at a tent outside of the hospital.  The patient medical history was not reported. There were no concomitant medications. No additional vaccines administered on same date of BNT162B2. No prior vaccinations within 4 weeks. The patient got Flu shot a long time ago for immunisation. No events occurred following prior vaccinations. The patient experienced bad rash all over body, very itchy on 20Dec2020 in the evening. The rash was driving her crazy.The reporter assessed the events were not really life threatening, not requiring hospitalization. Therapeutic measures were taken as a result of events: patient just bought Benadryl cream. No invesitgations. The outcome of events was unknown. She wanted to know if she has to get the second dose.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Cough, Headache, Neck pain, Pain in extremity
Clinical narrative: Arm pain on the left side, back pain, neck pain, headaches and then a dry cough developed several days later.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Pain
Clinical narrative: Headache; Body ache; Joint pain; This is a spontaneous report from a contactable consumer (patient).  A 31-year-old male patient received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, on 22Dec2020 at 11:00 AM at single dose for COVID-19 immunisation. Age at vaccination was 31-years-old. Medical history and concomitant medications were reported as none. On 22Dec2020, the patient developed headache, body ache, and joint pain. The patient reported the body ache has gotten worse, headache is still the same. The patient was treated with Advil. Outcome of all events was not recovered. Information on lot/batch number has been requested.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pruritus, Injection site warmth, Pain, Paraesthesia oral
Clinical narrative: Shortly after vaccination (within 15 min), patient experienced warmth and itching at injection site, some radiating pain.  Patient asked to stay longer to be observed, but eventually returned back to work without progress in symptoms.  Approximately an hour later, she was prompted by her supervisor to return to vaccine area when she developed a headache and tingly lips.  She was given 50mg of diphenhydramine PO.  In no apparent distress after dosing
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Oropharyngeal pain
Clinical narrative: Fatigue, Headache, Nausea, sore throat
Sex: U
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Achy pain at injection site; This is a spontaneous report from a non-contactable Other health care professional (HCP) (patient). A patient of an unknown age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on unknown date at single dose for COVID-19 immunization. Medical history and concomitant medications were not provided. On unknown date patient experienced achy pain at injection site. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort
Clinical narrative: GI problems; This is a spontaneous report from a contactable consumer (patient).   A 46-year-old female patient (weight 74.39 Kg) received the first dose of BNT162B2 (Pfizer-Biontech covid-19 vaccine, Lot. EK5730) on 18Dec2020, in the left upper arm, at single dose, for COVID-19 immunisation. Relevant medical history included thyroid disorder. Concomitant medications were unknown. On 18Dec2020, the patient experienced gastrointestinal (GI) problems. Clinical outcome of the adverse event was unknown at time of this report.